09:38 AM EDT, 08/08/2024 (MT Newswires) -- Immunocore Holdings ( IMCR ) shares rose 0.3% in recent Thursday trading after it posted a narrower Q2 net loss and higher revenue from a year earlier.

The biotechnology company reported a Q2 net loss of $0.23 per share, narrower than its loss of $0.35 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.37 per share.

Total revenue for the quarter ended June 30 was $75.4 million, up from $59.8 million a year earlier.

Analysts surveyed by Capital IQ expected $58.8 million.

Price: 37.00, Change: +0.10, Percent Change: +0.27